NAS:MDGS (Israel)  
Medigus Ltd logo

Medigus Ltd

$ 0.62 -0.0145 (-2.28%) 11:09 PM EST
P/E:
N/A
P/B:
1.11
Market Cap:
$ 15.27M
Enterprise V:
$ -10.10M
Volume:
17.25K
Avg Vol (2M):
109.84K
Also Trade In:
Volume:
17.25K
Market Cap $:
15.27M
PE Ratio:
N/A
Avg Vol (2-Month):
109.84K
Enterprise Value $:
-10.10M
PB Ratio:
1.11
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Medigus Ltd
NAICS : 339112 SIC : 3841
3 HaNechoshet Street, 5th Floor, Building B, Tel Aviv, ISR, 6971068
Description
Medigus Ltd is an Israel-based medical device company. It is engaged in the development, manufacturing, and marketing of surgical endostaplers and direct vision systems for minimally invasive medical procedures. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incisionless treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company also develops a range of micro video cameras under the micro ScoutCam portfolio of products. It operates in five segments: Medical, E-Commerce, Online, Electric Vehicles, and Corporate. The company's geographical segments include the United States, United Kingdom, Germany, Israel, China, and Others.
Name Current Vs Industry Vs History
Cash-To-Debt 16.92
Equity-to-Asset 0.82
Debt-to-Equity 0.03
Debt-to-EBITDA -0.21
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.11
Distress
Grey
Safe
Beneish M-Score 11.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 46.3
9-Day RSI 50.94
14-Day RSI 48.68
6-1 Month Momentum % -52.1
12-1 Month Momentum % -58.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.77
Quick Ratio 4.58
Cash Ratio 4.12
Days Inventory 58.51
Days Sales Outstanding 6.69
Days Payable 22.59

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -60.9

Financials (Next Earnings Date:2022-09-20 Est.)

MDGS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:MDGS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 10.118
EPS (TTM) ($) 0.2
Beta 1.84
Volatility % 34.66
14-Day RSI 48.68
14-Day ATR ($) 0.041886
20-Day SMA ($) 0.606544
12-1 Month Momentum % -58.7
52-Week Range ($) 0.555 - 1.78
Shares Outstanding (Mil) 491.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Medigus Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More